期刊文献+

血卟啉单甲醚荧光光谱法辅助诊断早期口腔癌 被引量:3

Hematoporphyrinmonomethyl Ether Fluorescence Spectrometry Auxiliary Diagnosis of Early Oral Cancer
下载PDF
导出
摘要 目的:应用动物模型探讨血卟啉单甲醚(hematoporphyrinmonomethyl ether,HMME)介导的荧光光谱法辅助诊断早期口腔癌的可行性。方法:21只金黄地鼠随机分成3组(对照组、5周组、9周组),每组7只,各组动物由DMBA诱导双侧颊囊相应时间后,按10ml/kg经腹腔注射20mg/L HMME溶液,用光谱诊断装置分别记录自体及HMME荧光,应用Origin7.0软件计算荧光比值K值,检测位点经病理切片HE染色定性.计算各组K值均值,SPSS10.0统计分析。结果:动物实验结果经方差分析,3组K值均值相比有统计学意义(P<0.01)。结论:HMME介导的荧光光谱法能够区分正常、异常增生和癌变组织,对口腔早期癌的诊断具有重要参考价值。 Objective:To investigate the feasibility of fluorescence spectra diagnosis of early oral cancer mediated with hematoporphyrinmonomethyl ether(HMME)in animal models.Methods:21golden hamsters were randomly divided into 3groups(control group,5weeks group and 9weeks group).Each group had 7animals.After induced by DMBA in corresponding weeks all the cheek pouches of animal models in each group were injected through intraperitoneal by 20ug/ml HMME solution as 10ml/kg.HMME fluorescence and auto-fluorescence spectrums were detected by fluorescence spectroscopy diagnosis system and were analyzed by Origin7.0to calculate fluorescence ratio K.All the detected points were determined by pathological diagnose.Mean K values were calculated and statistically analyzed by SPSS10.0.Results:The result of animal experiment was analyzed by ANOVA.It showed that the comparisons of K values among 3experiment groups had statistical significance(P〈0.01).Conclusion:Fluoresscent-spectro fluorometry method mediated by HMME could discriminate normal tissue,abnormal hyperplasia and cancer tissue.It had important reference value in diagnosis of early oral cancer.
出处 《口腔医学研究》 CAS CSCD 北大核心 2015年第7期699-701,共3页 Journal of Oral Science Research
基金 哈医大一院科研基金(项目编号:2014B19)
关键词 血卟啉单甲醚 光谱 口腔癌 诊断 金黄色地鼠 Hematoporphyrinmonomethyl ether Spectroscopy Oral cancer Diagnose Golden hamsters
  • 相关文献

参考文献2

二级参考文献25

  • 1El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med, 1999, 340: 745-750.
  • 2Ding X, Xu Q, Liu F, et al. Hematoporphyrin monomethyI ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation. Cancer Lett, 2004, 216: 43-54.
  • 3Mott JL, Gores GJ. Targeting IL-6 in cholangiocarcinoma therapy. AmJ Gastroenterol, 2007, 102: 2171-2172.
  • 4Bashshur ZF, Schakal A, Hamam RN, et al. Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age related macular degeneration. Arch Ophthalmol, 2007, 125: 1357-1361.
  • 5Wyld L, Reed MW, Brown NJ. Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br J Cancer, 2001, 84: 1384-1386.
  • 6Betz CS, Lai JP, Xiang W, et al. Invitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid. Photochem Photobiol Sci, 2002, 1 : 315-319.
  • 7Seki T, Wakabayashi M, Nakagawa T, et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer, 1999, 85: 1694-1702.
  • 8[1]Mehrotra R,Singh M,Kumar D,et al.Indian J Med Sci,2003,57 (9):400-404.
  • 9[2]Mehrotra R,Gupta A,Singh M,et al.Mol Cancer,2006,5:11.
  • 10[3]Filiurin MD.Stomatologiia (Mosk),1993,72(4):44-47.

共引文献15

同被引文献39

  • 1Stout AP. Juvenile fibromatosis [J]. Cancer, 1954, 7∶953Y978.
  • 2Lee JC, Thomas JM, Phillips S, et al. Aggressive fibromatosis: MRI features with patlvologic crrelation [J]. Am J Roentgcnol, 2006, 186(1)∶247-254.
  • 3McCarville MB, Hoffer FA, Adelman CS, et al. MRI and biologic behavior of desmiod tumors in childern [J]. Am J Roentgenol, 2007, 189(3)∶633-640.
  • 4Rodrignez ligas MA, Mahoney MC, Karakousis CP, et al. Desmiod tumours in patients with familial adenomatous polyposis [J]. Cancer, 1994, 74(4)∶1270-1274.
  • 5Tonelli F, Valanzano R, Brandi ML, et al. Pharmacological treatment of desmoid tumor in familiar adenomatous polyposis: results of a virtro study [J]. Surgery, 1994, 115(4)∶473-479.
  • 6Guillem JG, Wood WC, Moley JF, et al. ASCO/SSO review of current role of risk-reducing surgery in Common hereditary cancer syndromes [J]. J Clin Oncol, 2006, 24(9)∶4642-4660.
  • 7Wong SL. Diagnosis and management of desmoid tumors and fibrosarcoma [J]. J Surg Oncol, 2008, 97(3)∶554-558.
  • 8Hyodo M, Yumoto E, Wakisaka H, et al. Gastric scirrhous carcinoma as a rare cause of aggressive bromatosis in the neck [J]. Am J Otolaryngol, 2001, 22(1)∶38-42.
  • 9Meazza C, bisogno G, Gronchi A ,et al. Aggresive fibromatosis in children and adoleascents: The Italian excperience [J]. Cancer, 2010, 116(1)∶233-240.
  • 10Abdelkader M, Riad M, Williams A, et al. Aggressive fibromatosis of the head and neck (desmoid tumors) [J]. J Laryngol Otol, 2001, 115(10)∶772-776.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部